Human liver cancer cells and endothelial cells incorporate iodised oil
1996

How Iodised Oil Affects Liver Cancer Cells

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): S Bhattacharya, AP Dhillon, MC Winslet, BR Davidson, N Shukla, S Datta Gupta, R AL-Mufti, KEF Hobbs

Primary Institution: Royal Free Hospital and School of Medicine

Hypothesis

Do tumour cells incorporate lipiodol and if so by what mechanism?

Conclusion

Lipiodol is likely to deliver cytotoxic agents directly into tumour cells and endothelial cells, both in vitro and in vivo.

Supporting Evidence

  • Lipiodol was found in the cytoplasm of both tumour cells and endothelial cells.
  • The study demonstrated that lipiodol incorporation does not harm cell viability.
  • Hep G2 cells showed a slow rate of lipiodol uptake, while HUVECs showed rapid initial uptake.
  • Histological analysis revealed lipiodol in the majority of tumour vessels.
  • The study suggests that lipiodol may be used as a vehicle for targeted cancer treatment.

Takeaway

This study shows that a special oil can get into liver cancer cells, which might help deliver medicine directly to the cancer.

Methodology

In vitro assessments were performed on Hep G2 and HUVECs exposed to lipiodol, followed by histological analysis of HCCs in vivo.

Limitations

The study is preliminary and further in vivo dynamic studies are required to establish the mechanisms.

Participant Demographics

Included patients with solitary resectable HCC and chronic liver disease.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication